Efficiency and safety analysis of Plerixafor combined with granulocyte colony-stimulating factor on autologous hematopoietic stem cell mobilization in lymphoma  

作　　者：纪濛濛 JI Mengmeng(Shanghai Instit Hematol,State Key Lab,Medical Genomics at Shanghai,Natl Res Center,Translat Med,Ruijin Hosp,Shanghai Jiaotong Univ Sch Med,Shanghai 200025)

机构地区：[1]Shanghai Instit Hematol,State Key Lab,Medical Genomics at Shanghai,Natl Res Center,Translat Med,Ruijin Hosp,Shanghai Jiaotong Univ Sch Med,Shanghai 200025

出　　处：《China Medical Abstracts(Internal Medicine)》2023年第2期121-122,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To evaluate the advantages and safety of Plerixafor in combination with granulocyte colonystimulating factor(G-CSF)in autologous hematopoietic stem cell mobilization of lymphoma.Methods Lymphoma patients who received autologous hematopoietic stem cell mobilization with Plerixafor in combination with G-CSF or G-CSF alone were obtained.

关 键 词：HEMATOPOIETIC LYMPHOMA AUTOLOGOUS 

分 类 号：R733.1[医药卫生—肿瘤]